| abstract |
The present invention relates to a medicament comprising at least one reducing alkyl-sugar monomer whose hydroxyl function is substituted by a C 2 -C 40 alkoxy radical, said medicament is advantageously intended to regulate inflammatory mechanisms. The reducing sugar is advantageously chosen from the group consisting of rhamnose, fucose and glucose.n n n It also relates to a cosmetic treatment method by topical application of a composition comprising at least one reducing alkyl-sugar monomer, a hydroxyl function of which is substituted by a C 2 -C 40 alkoxy radical. |